MSMariana de Sousa Vilela Silva

Mariana de Sousa Vilela Silva

*This is an algorithmically generated author record based on publicly available information.

Mariana de Sousa Vilela Silva has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decoding akathisia: The significance of dopamine and dopaminergic pathways - a case report

    by Mauro Marques Lopes, Gustavo Coutinho Nogueira Pereira, Bruna Carvalho Veloso, Yuri Costa Anjos, Mariana de Sousa Vilela Silva, Fabiana Alves, Bárbara Faria Corrêa Vilela, Edmar Geraldo Ribeiro, Vinícius Corrêa da Silva Rocha

    Background: Dopamine and dopaminergic pathways are crucial in antipsychotic treatment and the emergence of akathisia. Understanding these mechanisms is essential for effectively managing this condition. Objective: This study aims to highlight the management of akathisia in a patient with schizophrenia while underscoring the significance of dopaminergic mechanisms in treatment. Methods: Following the CARE (CAse REports) guidelines, this study presents a case report that serves as a practical representation of clinical scenarios, contextualizing theoretical concepts through real-world examples, enhancing the understanding of rare conditions and unique treatment responses. Case Report and Discussion: A 59-year-old female patient diagnosed with schizophrenia developed severe akathisia after starting risperidone. She exhibited intense restlessness and emotional distress, requiring adjustments to her treatment regimen, including the addition of propranolol, clonazepam, and phenytoin. This case illustrates the intricate relationship between dopamine dysregulation and akathisia, emphasizing the necessity for personalized treatment strategies tailored to the patient's needs. It highlights the importance of close monitoring and flexible management in addressing adverse effects associated with antipsychotic medications. Furthermore, fostering a supportive therapeutic relationship with the mental health team and incorporating familial support significantly contributed to the patient's overall treatment success. Conclusion: Understanding dopaminergic pathways is vital for managing akathisia and schizophrenia. This study advocates for a holistic treatment approach that integrates clinical insights with psychosocial factors to improve the patient's quality of life and treatment adherence.

  • Open Access

    In-depth analysis of antipsychotic-induced akathisia: An integrative literature review

    by Mauro Marques Lopes, Gustavo Coutinho Nogueira Pereira, Bruna Carvalho Veloso, Yuri Costa Anjos, Mariana de Sousa Vilela Silva, Fabiana Alves, Bárbara Faria Corrêa Vilela, Edmar Geraldo Ribeiro, Vinícius Corrêa da Silva Rocha

    Background: Antipsychotic-induced akathisia poses a significant challenge in clinical practice due to its frequent oversight in diagnosis and associated severe consequences such as suicidal behavior and compromised treatment adherence. Understanding the underlying mechanisms and implementing effective management strategies are imperative in addressing this clinical concern. Objective: provide an updated understanding of the correlation between antipsychotics and akathisia, discussing its pathophysiology, diagnosis, assessment, and current as well as prospective treatment options. Methods: An integrative literature review was conducted utilizing Pubmed and Virtual Health Library databases, supplemented by additional resources to broaden the study's scope. Results and Discussion: Among the 204 studies analyzed, 17 met the criteria for inclusion in the review, complemented by 7 articles focusing on assessment scales. The study explores the impact of neuroleptic medications on akathisia's pathophysiology, diagnostic approaches, symptomatology, assessment tools, and management strategies. Conclusion: Robust research endeavors are crucial to consolidate evidence, identify gaps, and offer a holistic perspective on akathisia. The profound comprehension of the condition reveals paths to enhance patients' quality of life.